ETERNEX

Main information

  • Trade name:
  • ETERNEX 10 TAB
  • Dosage:
  • 3 ,10 ;MG
  • Pharmaceutical form:
  • TAB
  • Composition:
  • 10
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • ETERNEX 10 TAB
    India
  • Language:
  • English

Other information

Status

  • Source:
  • Central Drugs Standard Control Organization
  • Last update:
  • 09-08-2016

30-7-2018

ANSES recommends that certain populations avoid the consumption of food supplements containing melatonin

ANSES recommends that certain populations avoid the consumption of food supplements containing melatonin

Under the national nutrivigilance scheme, reports of adverse effects likely to be associated with the consumption of food supplements containing melatonin have been brought to the attention of ANSES. A retrospective analysis of these reports, combined with the considerable level of consumption of this type of supplement, led ANSES to conduct an assessment of the potential health risks. In its Opinion of February 2018, the Agency highlighted the existence of populations and situations at risk, for which t...

France - Agence Nationale du Médicament Vétérinaire

27-7-2018

Pending EC decision:  Slenyto, melatonin, Opinion date: 26-Jul-2018

Pending EC decision: Slenyto, melatonin, Opinion date: 26-Jul-2018

Europe - EMA - European Medicines Agency

15-5-2018

Orphan designation:  Melatonin,  for the: Treatment of neonatal encephalopathy

Orphan designation: Melatonin, for the: Treatment of neonatal encephalopathy

Europe - EMA - European Medicines Agency

7-8-2018

EU/3/16/1683 (Worphmed Srl)

EU/3/16/1683 (Worphmed Srl)

EU/3/16/1683 (Active substance: Melatonin) - Transfer of orphan designation - Commission Decision (2018)5407 of Tue, 07 Aug 2018 European Medicines Agency (EMA) procedure number: EMA/OD/007/16/T/01

Europe -DG Health and Food Safety

7-8-2018

EU/3/16/1682 (Worphmed Srl)

EU/3/16/1682 (Worphmed Srl)

EU/3/16/1682 (Active substance: Melatonin) - Transfer of orphan designation - Commission Decision (2018)5406 of Tue, 07 Aug 2018 European Medicines Agency (EMA) procedure number: EMA/OD/001/16/T/01

Europe -DG Health and Food Safety

7-8-2018

EU/3/18/1996 (Worphmed Srl)

EU/3/18/1996 (Worphmed Srl)

EU/3/18/1996 (Active substance: Melatonin) - Transfer of orphan designation - Commission Decision (2018)5409 of Tue, 07 Aug 2018 European Medicines Agency (EMA) procedure number: EMA/OD/227/17/T/01

Europe -DG Health and Food Safety

7-8-2018

EU/3/16/1755 (Worphmed Srl)

EU/3/16/1755 (Worphmed Srl)

EU/3/16/1755 (Active substance: Melatonin) - Transfer of orphan designation - Commission Decision (2018)5408 of Tue, 07 Aug 2018 European Medicines Agency (EMA) procedure number: EMA/OD/127/16/T/01

Europe -DG Health and Food Safety

18-4-2018

Melatonin (haemorrhage) (Therapicon Srl)

Melatonin (haemorrhage) (Therapicon Srl)

Melatonin (haemorrhage) (Active substance: Melatonin) - Refusal of orphan designation - Commission Decision (2018)2410 of Wed, 18 Apr 2018 European Medicines Agency (EMA) procedure number: EMA/OD/127/17

Europe -DG Health and Food Safety

23-3-2018

EU/3/18/1996 (Therapicon Srl)

EU/3/18/1996 (Therapicon Srl)

EU/3/18/1996 (Active substance: Melatonin) - Orphan designation - Commission Decision (2018)1885 of Fri, 23 Mar 2018 European Medicines Agency (EMA) procedure number: EMA/OD/227/17

Europe -DG Health and Food Safety

15-3-2018

Melatonin (burns) (Therapicon Srl)

Melatonin (burns) (Therapicon Srl)

Melatonin (burns) (Active substance: Melatonin) - Refusal of orphan designation - Commission Decision (2018)1643 of Thu, 15 Mar 2018 European Medicines Agency (EMA) procedure number: EMA/OD/039/17

Europe -DG Health and Food Safety